window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : March 4, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

robotics

  • Artificial Intelligence,Biomanufacturing,Digital Health,Drug Development,Technology and platforms

    The path to the autonomous lab: balancing innovation, culture, and compliance

    Laboratories across the pharmaceutical industry are moving closer to full [...]

    October 16, 2025
  • Cell & Gene Therapy,Medical devices,Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    August 25, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Data Management,European biotech,Research & Development

    Labguru and Titian Software rebrand as Cenevo to accelerate scientific discovery

    Labguru and Titian Software have rebranded under a unified identity, [...]

    July 31, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices
    Categories: Clinical studies, Digital Health, Drug Delivery & Formulation, Neurosciences
  • Promatix shows 50-fold potency in colorectal cancer with PBS293 ADC
    Categories: Biotech, Drug Development, Drug discovery, Oncology
  • SolasCure phase 2 trial shows faster healing in venous leg ulcers
    Categories: Clinical Trials, Dermatology, Drug Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top